NTRK2 and metastatic malignant neoplasm in the lymph nodes: TrkB immunostaining was stronger in NSCLCs with lymph node metastasis compared with those node negative cases and a statistically significant correlation between higher TrkB expression and positive node was found (P = 0.028).